A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them. And billing headaches are common. Here's how to overcome those hurdles.
Three clinical trial sites in Atlanta contributed significantly to the so-named "PURPOSE" study for PrEP by enrolling the population at highest risk for HIV acquisition.
A rule enacted by the Biden administration that took effect for many Affordable Care Act plans on Jan. 1 should make it easier for people like Wilkins to get long-acting PrEP injectable drugs — a new Trump administration adds an X factor to this and other federal health programs.
A significant number of new HIV infections happen among Black women, and a health education effort in Atlanta wants to make sure Black women can access the HIV-prevention medicines known as PrEP.
Republicans in Congress back substantial cuts to the budget of the CDC, taking aim at one of former President Donald Trump's major health programs: a push to end the HIV epidemic in the U.S.
Some object to paying for health insurance plans that cover preventive services that they say violate their religious beliefs, which could cause millions to lose access to care if the courts agree.
The Food and Drug Administration this week approved an injectable drug that helps prevent the spread of HIV. It only has to be taken once every eight weeks, compared to a daily oral pill.
The drugs only need to be taken a few times a year — and may soon be available in many parts of the world. Patients say they are more convenient and less stigmatizing.
